Taubert Jennifer L
EVP, WWC. Innovative Medicine at JNJ
- Sold, on record
- $36.9M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Aug 17, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- JNJJOHNSON & JOHNSONEVP, WWC. Innovative Medicine
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale JNJUnusualNov 22, 2022 2022
Sold 76,923 shares at $176.78 ($13.6M)
Taubert Jennifer L, EVP, WW Chair, Pharmaceuticals
Sold 37.8% of holdings ($36M position)126,456 shares leftFirst sale on recordFiling
- 2 Form 144 notice JNJNoticeFeb 9, 2024 +444 days
Filed to sell 59,397 shares ($9.3M)
Taubert Jennifer L, Officer
No 10b5-1 planFiling
- 3 Form 4 sale JNJUnusualFeb 9, 2024 same day
Sold 59,397 shares at $156.27 ($9.3M)
Taubert Jennifer L, EVP, WW Chair, Pharmaceuticals
No 10b5-1 planSold 29.6% of holdings ($31.4M position)141,416 shares leftFollows a Form 144Filing
- 4 Form 4 sale JNJNo planSep 4, 2025 +573 days
Sold 56,471 shares at $177.81 ($10M)
Taubert Jennifer L, EVP, WWC. Innovative Medicine
No 10b5-1 planSold 24.1% of holdings ($41.7M position)178,013 shares leftFiling
- 5 Form 4 sale JNJNo planAug 17, 2026 +347 days
Sold 15,000 shares at $263.36 ($4M)
Taubert Jennifer L, EVP, WWC. Innovative Medicine
No 10b5-1 planSold 7.2% of holdings ($55.2M position)194,451 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Aug 18, 2026 | JNJ | EVP, WWC. Innovative Medicine | Form 4 sale | 15,000 | $4M | 7.2% | No plan | SEC |
| Sep 4, 2025 | Sep 5, 2025 | JNJ | EVP, WWC. Innovative Medicine | Form 4 sale | 56,471 | $10M | 24.1% | No plan | SEC |
| Feb 9, 2024 | Feb 12, 2024 | JNJ | EVP, WW Chair, Pharmaceuticals | Form 4 sale | 59,397 | $9.3M | 29.6% | Unusual | SEC |
| Feb 9, 2024 | Feb 9, 2024 | JNJ | Officer | Form 144 notice | 59,397 | $9.3M | Notice | SEC | |
| Nov 22, 2022 | Nov 23, 2022 | JNJ | EVP, WW Chair, Pharmaceuticals | Form 4 sale | 76,923 | $13.6M | 37.8% | Unusual | SEC |